* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *

Centocor

                   
startribune.com: startribune.com

J&J Finds Drug To Help Crohn's Sufferers

cbs3.com
yesterday 18 related
        

TRENTON (AP) ― An injected Johnson & Johnson biologic drug used to treat several immune diseases controlled Crohn's disease, a difficult-to-treat bowel disorder, better than a widely used pill, a study found. Run by J&J's...

add comment
                   

Is it Lilly? ImClone Stays Mum on Mystery Big Pharma Bidder

tmcnet.com
02-Oct-2008 17 related
        

With two blockbuster products set to lose patent protection in the next two to three years, Eli Lilly and Co. certainly seems like a firm that would be willing to pay $70 per share - about $6.1 billion - to acquire ImClone...

add comment

Venrock Expands Digital Media Franchise With Addition of David Pakman as Partner

finanznachrichten.de
02-Oct-2008 6 related
        

Venrock, the premier venture capital firm originally established as the venture arm of the Rockefeller family, announced today that David Pakman has joined the firm as a partner and will focus on digital media investments in...

add comment
                   

Arana Completes Series Of Humanised And Improved Antibodies For Vegenics' Cancer Treatment Program

medicalnewstoday.com
02-Oct-2008
        

Antibody therapeutics company Arana Therapeutics Limited (ASX:AAH) and biologics drug development company Circadian Technologies Limited (ASX:CIR) today announced that Arana has successfully engineered an improved version of...

add comment

Celator Pharmaceuticals appoints new CEO

pharmaceutical-business-review.com
01-Oct-2008
        

US based Celator Pharmaceuticals has appointed Scott Jackson as the company's new CEO. Mr Jackson succeeds Andrew Janoff. Celator Pharmaceuticals appoints new CEO Celator reports positive results from Phase II colorectal cancer...

add comment
yahoo.com: Martin Mackay yahoo.com

Pfizer to Cut R&D Jobs, Retreat from Heart-Drug Research (at The Wall Street Journal Online)

yahoo.com
30-Sep-2008 14 related
        

In its ongoing struggle to re-invent itself, Pfizer’s going to announce today that it’s cutting R&D staff and largely getting out of the business of making new medicines for heart disease, the WSJ reports. It’s also largely...

add comment

Centocor St. Louis

biofind.com
29-Sep-2008
        

Where have all the messages gone? Guess if you did not use full names the postings would still be up. In the biotech community sounds like the "roadrunner" transistion, as you all call it, is happening. Goodluck to you...

add comment

Immunogen: The Time Has Come

istockanalyst.com
23-Sep-2008
        

“It has been a tough time for biotech investors, but a strong biotech rally may be just around the corner,” says leading biotech analyst John McCamant.Here, the editor of The Medical Technology Stock Letter looks at a...

add comment
                   

AppNexus Secures $8 Million in Series B Funding

vcaonline.com
23-Sep-2008 1 related
        

Venrock Leads Latest Round; Mike Tyrrell Joins Board NEW YORK, September 23, 2008-- AppNexus, a leading provider of enterprise-class cloud computing solutions, today announced that it has raised $8 million in Series B...

add comment

Greg MacMichael, Ph.D., joins Cook Pharmica as Vice President of Development, CSO

cookmedical.com
22-Sep-2008
        

Bloomington, Ind., September 22, 2008 – Greg MacMichael, Ph.D. has joined Cook Pharmica, the global biopharmaceutical contract development and manufacturing division of Cook Medical, as vice president of development and...

add comment
1 2 3 4 5 next »